GenScript Biotech Corporation (GenScript Bio) announced that its Board of Directors will convene on Saturday, 15 August 2026 in the United States.
The meeting’s agenda includes: 1. Reviewing and approving the unaudited interim results for the six months ended 30 June 2026. 2. Authorising publication of the interim financial statements. 3. Considering the declaration of an interim dividend, if any.
The notice, dated 5 August 2026 and signed by Chairman and Executive Director Robin Meng, confirms that any discrepancies between the English and Chinese versions of the announcement will be governed by the English text.
The Board currently comprises four executive directors and six independent non-executive directors.
Comments